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Periodontal disease is one of the most common diseases worldwide. It has a significant
impact on oral health and subsequently the individual’s quality of life. However,
optimal regeneration of periodontal tissues, using current treatments, has yet to be
achieved. Peptide self-assembly has provided a step-change in nanobiotechnology
and regenerative medicine fields. Our aim was to investigate the effects of a self-
assembling peptide (SAP; P11-4) on periodontal regeneration in a preclinical model.
Twenty-six bilateral maxillary critical-sized periodontal defects were created surgically in
13 rats. Defects on one side of the mouth were filled with P11-4 hydrogel; the contra-
lateral defect was untreated (control). Rats were sacrificed immediately post-surgery
(time 0) and after 2 and 4 weeks. Retrieved maxillae were processed for histological,
immunohistochemical, and histomorphometric assessments. The results of histological
analysis showed greater organization of periodontal fibers in defects treated with P11-4,
at both time points, when compared to untreated defects. Histomorphometry showed
that treated defects had both a significant increase in functional periodontal ligament
length and a reduction in epithelial down growth after 4 weeks. At 2 weeks, treated
defects showed a significant increase in expression of osteocalcin and osteoprotegerin
as judged by immunohistochemistry. Also, a significantly higher osteoprotegerin/RANKL
ratio was shown in treated defects. In conclusion, the results demonstrated enhanced
regeneration of periodontal tissues when SAP P11-4 was used to fill periodontal defects
in rats. The findings of this study suggest that SAP P11-4 is a promising novel candidate
for periodontal regenerative therapy. Further investigations are required for optimization
before clinical use.
Keywords: regenerative medicine, biomaterial(s), periodontal disease(s)/periodontitis, nanotechnology,
histochemistry
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INTRODUCTION
Periodontal disease (PD) adversely affects oral function and
esthetics and is a major cause of tooth loss in older adults
(Petersen and Ogawa, 2012). In addition, untreated chronic
inflammatory PD has been linked to systemic diseases, such
as cardiovascular disease (Humphrey et al., 2008). Successful
management of PD is, therefore, of central importance not only
to oral health but to health per se.
The complexity of the three dimensional architecture and
tissue composition of the periodontium pose challenges to
healing and restoration of full function following destruction by
PD (Ivanovski et al., 2014). Conventional treatment strategies
halt the progression of disease but may not produce full
regeneration of periodontium (Susin et al., 2015). Contemporary
surgical treatment enhances periodontal regeneration (PR)
through the use of graft materials (Trombelli et al., 2002), growth
factors (Kitamura et al., 2016), root surface conditioning (Karam
et al., 2016), and guided tissue regeneration (Reynolds et al.,
2015) but with sometimes undesirable or unpredictable results
(Susin et al., 2015). Alloplastic biomaterials such as ceramics and
polymers can overcome these limitations but optimal periodontal
reconstruction has yet to be achieved (Lee et al., 2012).
Regenerative therapies are continuing to be developed as
potential solutions to intractable clinical problems. A recent
review by the American Academy of Periodontology (Lin et al.,
2015) concluded that ongoing research in regenerative medicine
has led to the development of novel treatment approaches and
technologies for PD, including the use of nanomaterials, to
improve treatment outcomes (Lin et al., 2015).
There has been a growing interest in self-assembling peptides
(SAPs) as nanomaterials for use in regenerative medicine,
including as candidates for periodontal regenerative therapy, due
to their unique properties (Takeuchi et al., 2016). Zhang and
colleagues led the way in developing this technology for use in
regenerative therapies (Zhang, 2002).
Self-assembling peptides used in regenerative medicine
offer the advantages of being biocompatible, biodegradable
and, where required, bioactive. Peptide self-assembly into
macromolecular structures mimics natural biological processes
(e.g., collagen fibrillogenesis in bone and amelogenin self-
assembly in developing enamel) (Palmer et al., 2008), generating
three dimensional hydrogel scaffolds with properties similar
to extracellular matrices (ECMs). These hydrogels have shown
to support cell attachment, proliferation and differentiation, in
addition to initiating biomineralization and promoting wound
healing (Holmes et al., 2000; Webber et al., 2010).
Self-assembling peptide P11-4 was developed as a biomimetic
material reflecting the properties of ECMs in mineralized tissues
(Kirkham et al., 2007; Kyle et al., 2009; Brunton et al., 2013)
and is currently used clinically in the treatment of early caries of
enamel. P11-4 is a promising candidate in regenerative therapies
(Schmidlin et al., 2016) but its full potential has yet to be
explored. We hypothesized that P11-4 would promote PR based
upon its known biocompatibility (Saha et al., 2019) and ability
to repair mineralized tissues (Jablonski-Momeni and Heinzel-
Gutenbrunner, 2014). Our aim was to investigate the use of P11-4
hydrogels on periodontal ligament (PDL) and alveolar bone (AB)
regeneration in surgically created periodontal defects in rats.
MATERIALS AND METHODS
Rheology of P11-4 as a Function of
Concentration
All rheological measurements were carried out on an Anton
Paar MCR 302 (Leeds School of Dentistry). Rheo Compas s1.20
by Anton Paar was used to control and export the raw data.
A parallel plate geometry with a diameter of 50 mm and a gap
of 0.1 mm was used. All tests were run at 37◦C with a solvent trap
to prevent the evaporation of the aqueous medium. Samples of
concentrations 15, 30, and 60 mg/ml were prepared by weighing
out the required amount of lyophilized P11-4 dissolving in PBS
and pH adjusting with aliquots of HCl, following this the gels
were then drawn up into a hypodermic syringe. All gels were left
to equilibrate for 48 h, after which they were dispensed through
the syringe onto the geometries for immediate testing. P11-4 at
concentrations of 15, 30, and 60 mg/ml were probed with an
amplitude sweep in a controlled shear strain state from 0.01 to
100% at 1 and 20 HZ, this determined the linear viscoelastic
region (LVER), in which a strain value that lay within this
region was chosen. The dynamic modulus was then probed via
a frequency sweep for each sample, at the strain value that was
established from the amplitude sweep.
Preparation of SAP P11-4
Freeze-dried P11-4 (CH3COOQQRFEWEFEQQNH2) was
obtained from Credentis AG (Zurich) with a purity of 98%
by HPLC and sterilized using gamma irradiation. Sterile SAP
gels were prepared in PBS at least 48 h before surgery at a
concentration of 60 mg/ml (pH 7.4). The prepared peptide
solutions were drawn up into hypodermic syringe barrels and
were allowed to form gels in the syringes over a minimum of
48 h to complete the self-assembly process. The SAPs were
then delivered directly from the syringes to the defects on
the day of surgery.
Animals
Thirteen male, pathogen free, Sprague Dawley rats each weighing
150–200 g were used in this study. All experimental procedures
were performed according to a protocol approved by the Ethical
Committee of the Faculty of Dentistry, Mansoura University,
Egypt. The rats were kept under conditions of controlled
temperature, humidity and with a 12:12 h light-dark cycle.
Animals received standard rat chow and water ad libitum unless
otherwise stated below.
Surgical Protocol and Study Design
The study design is illustrated in Supplementary Appendix
Table S1. All surgeries were carried out under aseptic
conditions at the University of Mansoura. Animals were
anesthetized by intraperitoneal injection using ketamine as
described previously (Padial-Molina et al., 2012). Surgical
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bilateral maxillary periodontal defects were created in each hemi-
maxilla, just mesial to the first maxillary molar (Bizenjima et al.,
2015). Briefly, a 3 mm sagittal surgical incision was made on
the crest of the alveolar ridge using a size #11 surgical blade.
Buccal and palatal flaps were raised to expose the mesial root of
the maxillary first molar. Bilateral critical-sized surgical defects
(2 mm × 2 mm × 1.7 mm) were created in the AB using a
round bur (1 mm diameter) with a long shank accompanied
by cooling with physiological saline solution. A small, sharp
curette was used to perform curettage and root planning of
the mesial root surfaces to ensure removal of any residual PDL
(Figure 1). Defects were then irrigated with physiological saline
to flush out any debris. One defect/animal was filled with P11-
4 hydrogel from a syringe; the contra-lateral defect remained
empty. To close the wound, buccal and palatal gingival edges were
approximated and stabilized with cyanoacrylate glue (Histoacryl R©
B. Braun Surgical, S.A. Carretera de Terrassa, 121, 08191 Rubi,
Spain). After recovery from anesthesia, Ketoprofen (5 mg/kg)
was provided as analgesic for 3 consecutive days. Ampicillin,
268 mg/L, added to a 5% dextrose solution was given via the
FIGURE 1 | (A) Showing magnified view of 3 mm crestal incision, mesial to the maxillary first molar (white arrow) and (B) critical-sized periodontal surgical defect
(2 mm × 2 mm × 1.7 mm) (black arrow) adjacent to the mesial root of a maxillary first molar (white arrow). (C) Illustration of histomorphometric analysis of H&E
stained sections. The numbers from one to five indicate the reference level of intact alveolar bone, the length of the first molar mesially from apex to cusp, the length
of the epithelium from the free gingival margin to the most apical extent, the length of functional ligament, and length of bone gap till most coronal extent of new
bone, respectively. (A); bar = 10 mm, (B); bar = 5 mm, (C); bar = 500 µm.
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drinking water as antibiotic treatment (Padial-Molina et al.,
2012). Dextrose (5%) was added to the drinking water for a
total of 7 days post-surgery to augment nutrition following the
intra-oral surgery. One rat was euthanized on the day of surgery
(Day 0), six rats were euthanized 2 weeks post operatively while
the remaining rats (n = 6) were euthanized after 4 weeks. The
maxillae of both groups were harvested for histology processing.
Histological Analysis of Retrieved
Defects
Once harvested, all specimens were fixed for 48 h in 10% neutral
buffered formalin. Each maxilla was divided into two halves,
rinsed with distilled water and then transferred to 10% neutral
buffered EDTA for decalcification. EDTA solution was changed
daily for approximately 4 weeks. The decalcified hemi-maxillae
were then processed and wax embedded for transfer to Leeds.
Serial sections (7 µm thickness) were obtained from the central
portion of the root and every tenth section was stained with
hematoxylin and eosin (H&E) with adjacent slides used for
immunohistochemistry (see below). Stained sections were viewed
in the Olympus BX51 bright field/fluorescence microscope and
images captured with a Nikon Ds-Fi1 digital camera using Nikon
NIS Elements imaging software (v3.1) for histomorphometric
analysis as described below.
Histomorphometric Analysis
Hematoxylin and eosin stained sections of periodontium
including the defects, located mesial to the mesial root of the
maxillary first molar, were assessed for newly formed bone,
newly formed functional PDL (defined as described below) and
junctional epithelial down-growth. Three sections per hemi-
maxilla per animal were subjected to analysis. Thus, a total of
72 H&E stained sections (18 sections per group) were evaluated.
The quantitative data were normalized to tooth length in order
to compensate for any differences in cutting angulation between
samples (Figure 1). The following parameters were assessed by
ImageJ digital image analysis (Oortgiesen et al., 2013; Yan et al.,
2015) then subjected to statistical analysis:
Relative Alveolar Bone Height
A line was drawn at the level of the furcation height as a
reference to normal bone height. A line representing the length
of the molar was measured from the apex of the mesial root
to the cusp. The line parallel to that of the root and extending
from the reference line to the level of regenerated bone surface,
representing alveolar bone gap, was measured. Relative alveolar
bone height was determined by dividing the mesial molar length
by the length of bone gap. A higher score indicates superior
height of newly formed bone.
Relative Epithelial Down-Growth
The length of the epithelium was measured from the gingival
margin to the most apical extent of junctional epithelium.
Epithelial down-growth was calculated via dividing epithelial
length by the length of the mesial molar. A higher score indicates
greater epithelial down-growth.
Relative Functional Ligament Length
Collagen fibers were included in histomorphometry when the
main fibers formed an angle >60◦ to the long axis of the root
(functional PDL). The length of functional ligament was divided
by the length of the molar to obtain the relative functional
ligament length (Oortgiesen et al., 2013; Yan et al., 2015).
Immunohistochemical Analysis
Paraffin sections were de-waxed in xylene and processed for
immunohistochemical evaluation of expression of proliferating
cell nuclear antigen (PCNA), osteocalcin (OCN), collagen type
I (COL I), osteoprotegerin (OPG), and receptor activator
of nuclear factor kappa-B ligand (RANKL). Supplementary
Appendix Table S2 shows the antibodies used in this study,
along with their optimized dilutions. Sodium citrate was used for
antigen retrieval and immunohistochemical staining performed
according to the manufacturer’s instructions for each second
antibody used. A total of 360 sections were assessed (72 sections
per antibody). For each antibody, three sections per hemi-
maxilla per animal were analyzed (18 sections per group).
Serial sectioning of the specimens enabled the evaluation of
three sections per antibody: one section from the surface,
one from the central portion and one from the deep part of
the defect area. Images were acquired in the Olympus BX51
bright field/fluorescence microscope at a fixed magnification
(×200) and field [connective tissue (CT) adjacent to the root
and immediately above the newly formed AB] as described
previously. Digital image analysis was used to quantify the
proportion of PCNA positive cells. The % area of positive
expression was determined for OCN, OPG, and RANKL and
the OPG/RANKL ratio calculated (Tan et al., 2009; Peng et al.,
2013; Ross, 2014). Observations for COL I connective tissue fiber
organization were recorded but slides stained for COLI were not
subjected to quantitative analysis given the predominance of type
I collagen in all of our samples.
Statistical Analysis
Mead’s resource equation was used to determine appropriate
sample size for the animal experiment (Chen et al., 2016). The
data collected from histological and immunohistochemical
analyses was analyzed using SPSS v17. Results were
expressed as means ± SD. The distribution of all variables
was examined for normality using Shapiro-Wilk normality
testing. Quantitative analysis parameters were compared using
independent samples T-test and the significance level was set at
p < 0.05.
RESULTS
Characterization of P11-4 Hydrogel
In order to determine the optimum peptide concentration of P11-
4 to administer it was hypothesized that the material must remain
in a gel like state as opposed to a solid like ‘paste’ or a weak
‘viscoelastic fluid.’ The material properties were therefore tested
to optimize the gel stiffness. In all cases the storage modiolus,
G’, corresponding to the elastic component is greater than the
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loss modiolus, G′′, corresponding to the viscous component
indicating gel like behavior. Figure 2 shows that both G′ and
G′′ increase as a function of concentration, indicating that the
stiffness of the gels increases as a function of concentration. In
the highest concentration we have retained the desired material
properties but increased the stiffness by orders of magnitude
when compared with the lowest concentration. As the material
intervention must remain in situ despite mechanical forces
applied through normal mastication it was concluded that the
most appropriate concentration to take into our animal model
was the stiffest gel concentration (60 mg/ml).
Histological Observations
Both P11-4-treated and untreated defects retrieved after 2 and
4 weeks post-surgery showed evidence of newly formed
CT, compared with Day 0 defects but the histological
appearance/organization of these tissues appeared superior
after treatment with P11-4 compared to the untreated defects
with respect to fiber orientation and bone architecture (Figure 3).
P11-4-treated defects showed high condensation of newly
formed blood capillaries directly adjacent to AB at 2 weeks,
suggesting enhanced angiogenesis, which is potentially beneficial
for tissue regeneration and wound healing. In addition, newly
formed gingivae displayed highly organized fibers and oriented
fibroblasts at both time points after P11-4 treatment. Superior
orientation of newly formed oblique PDL fibers was also evident.
The amount of new bone in P11-4-treated defects was not
obviously different to that in untreated defects but any new bone
was well-constructed with improved trabecular structure at 2 and
4 weeks in the P11-4-treated defects. On the other hand, untreated
defects showed far less organized newly formed gingiva, PDL
fibers and bone (Figure 3).
Finally, inflammatory cell infiltrates in the gingival sulcus and
gingival CTs were seen in untreated but not P11-4-treated defects
after 2 weeks (Figure 3).
Histomorphometric Analysis of H&E
Sections
There were no significant differences in relative epithelial down-
growth and relative functional PDL length between P11-4-treated
and untreated defects at 2 weeks post-surgery. However, relative
epithelial down-growth significantly decreased while relative
functional PDL length increased after P11-4 treatment compared
with untreated defects after 4 weeks (p < 0.05).
There were no significant differences in AB height




Greater levels of OPG expression were noted in P11-4-treated
defects at 2 and 4 weeks post-surgery, while RANKL expression
appeared comparable in both untreated and P11-4-treated groups
at both time points (Figure 4). Quantitative analysis showed
that compared with untreated defects, OPG expression was
significantly higher in P11-4-treated defects at both 2 and
4 weeks (p < 0.05). Moreover, the mean OPG/RANKL ratio
was significantly higher in the P11-4-treated group at both
2 and 4 weeks suggesting greater potential for osteogenesis.
RANKL expression showed no significant differences at either
time point (Table 1).
Positive OCN expression appeared to be higher in the
P11-4-treated groups when compared to the untreated groups
FIGURE 2 | The effect of varying the concentration on the mechanical properties of P11-4 showing that upon increasing concentration the stiffness of the gel
increases.
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FIGURE 3 | Representative images showing histopathological overview after 2 and 4 weeks of healing (H&E staining) in untreated and P11-4-treated defects. Upper
panel (A–D) shows the gingival region of the defects while lower panel shows the apical region of the defects (E–H). At 2 weeks the untreated group showed
evidence of inflammatory cell infiltrate in the gingival connective tissue and gingival sulcus (arrows) (A) while the P11-4-treated group appeared to show healthier
gingival healing with connective tissue and periodontal ligament demonstrating better organization of fibers and cells (arrow) (B). Gingiva and periodontal ligament at
4 weeks also showed enhanced structure in the P11-4-treated group (asterisks) (D,H). Newly formed bone structure and trabecular organization appeared to be
superior in P11-4-treated groups at 2 and 4 weeks (arrows) (E–H). Gingiva (GI), dentin (DE), cementum (CE), periodontal ligament (PDL), and new bone (NB). (A–H)
×100; bar = 100 µm.
TABLE 1 | Showing histomorphometric analysis results and quantitative analysis of immunohistochemical stains.
2 weeks’ time point 4 weeks’ time point
Data represents No treatment SAP P11-4 No treatment SAP P11-4
Relative functional ligament length 0.3 ± 0.04 0.29 ± 0.13 0.08 ± 0.07 0.42 ± 0.04*
Relative epithelial down-growth Measurements in µm 0.15 ± 0.01 0.146 ± 0.01 0.14 ± 0.01 0.09 ± 0.01*
Relative alveolar bone height 3.80 ± 1.54 2.57 ± 0.33 4.13 ± 0.86 5.33 ± 0.28
PCNA Mean % of positive cells count/total cells count 19.7 ± 0.7 21.2 ± 2.8 21.2 ± 0.4 22.3 ± 3.1
OCN Positive mean % area 14.0 ± 0.9 23.5 ± 2.1* 14.9 ± 1.5 17.4 ± 4.0
OPG 24.7 ± 3.2 31.4 ± 2.4* 18.1 ± 1.4 26.9 ± 1.8*
RANKL 27.9 ± 2.5 31.2 ± 3.3 23.8 ± 2.0 29.9 ± 5.5
OPG/RANKL 0.9 ± 0.04 1.0 ± 0.04* 0.8 ± 0.03 0.9 ± 0.11*
Data shown as mean ± SD (median 95% confidence interval) calculated by independent samples T-test with Levene’s test for equality of variances (p < 0.05). *Significant
values of P11-4 when compared with untreated group at the same time point.
at 2 and 4 weeks (Figure 5). This was confirmed using
quantitative analysis at the earlier time point (p < 0.05)
but OCN expression in the P11-4-treated defects compared
with untreated defects was not significantly different after
4 weeks (Table 1).
Collagen type-I expression was seen in our area of interest,
adjacent to the root and just coronal to the newly formed bone,
in both treated and untreated defects. Fibers were, however,
more highly organized and aggregated into uniform bundles
of similar orientation in the P11-4-treated defects after 2 and
4 weeks when compared with untreated defects. Furthermore,
comparing the P11-4-treated defects after 4 weeks with those after
2 weeks showed a continued improvement in CT architecture,
as the fibers displayed a tighter arrangement and higher level of
organization, as opposed to the untreated defects which showed
limited organization of CT (Figure 5).
The proportion of PCNA positive cells in the designated
fields appeared comparable when evaluating both groups at 2
and 4 weeks post-surgery (Figure 6). Statistical analysis revealed
that there were no significant differences in the proportion of
PCNA positive cells between P11-4-treated and untreated defects
whether at 2 or 4 weeks (Table 1).
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FIGURE 4 | Representative photomicrographs of immunohistochemical staining for osteoprotegerin (OPG) (A–D) and receptor activator of nuclear factor kappa-B
ligand (RANKL) (E–H) in untreated and P11-4-treated defects. Connective tissue areas adjacent to the root and immediately above the newly formed bone are
shown (original magnification; ×200; bar = 50 µm). OPG expression appeared to be higher in P11-4-treated defects when compared with the untreated defects at 2
and 4 weeks (A–D), while RANKL expression seemed comparable in untreated and P11-4-treated groups at both time points (E–H). See Table 1 for quantitative
values of mean % area for OPG and RANKL, in addition to the mean OPG/RANKL ratios.
FIGURE 5 | Representative photomicrographs of immunohistochemical staining for osteocalcin (OCN) (A–D) and collagen type I (COL I) (E–H) in untreated and
P11-4-treated defects. Connective tissue areas adjacent to the root and immediately above the newly formed bone are shown (original magnification; ×200;
bar = 50 µm). Positive OCN expression seemed to be higher in the P11-4-treated groups when compared to the untreated groups at 2 (A,B) and 4 (C,D) weeks
post-surgery. Newly formed COL I fibers appeared to be more developed and more regularly arranged in P11-4-treated groups at 2 (E,F) and 4 (G,H) weeks
post-surgery.
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FIGURE 6 | Representative photomicrographs of immunohistochemical staining for proliferating cell nuclear antigen (PCNA) at 2 (A,B) and 4 (C,D) weeks
post-surgery in untreated and P11-4-treated defects. Connective tissue areas adjacent to the root and immediately above the newly formed bone are shown (original
magnification; ×200; bar = 50 µm). The number of PCNA positive cells in both groups appeared comparable at both time periods.
DISCUSSION
The present study was conducted to evaluate the effects of SAP
P11-4 on regeneration of PDL and AB. SAP P11-4 hydrogels
were developed specifically for CT regeneration (Aggeli et al.,
2003) and are available commercially for treatment of early
carious lesions. To the best of our knowledge the current work
represents one of the first in-vivo studies to evaluate the possible
application of P11-4 in the regeneration of periodontal tissues in
a critical sized defect.
Although P11-4 was developed to self-assemble with a
charged based trigger mechanism its assembly is still inherently
concentration dependent. Therefore, it was hypothesized and
shown here that increasing the concentration would yield a
stiffer gel. P11-4 has shown to be a successful material in
treating caries lesions at 10 mg/ml (Brunton et al., 2013)
and more recently Saha and colleagues have demonstrated
that at 30 mg/ml P11-4 is a suitable scaffold for the
regeneration of bone in a cranial defect (Saha et al., 2019).
Both applications are in areas whereby the mechanical forces
on the scaffold its-self are shielded. In this study, however,
the regenerative site is known to be under significant force
during mastication and to a lesser extent from the applied
forces from secreted crevicular fluid in the cavity. It was
prudent to develop a formulation that would allow for the
SAP matrix to be retained under these forces therefore a
concentration with the highest possible elastic and viscoelastic
modulus (60 mg/ml) was used to prevent seepage from
the treated site.
The results of our study suggested that P11-4 enhanced
regeneration of periodontal tissues over a period of 4 weeks
following surgical induction of critical-sized surgically induced
defects. No evidence of local adverse reactions were seen in
association with P11-4, indicating good biocompatibility as
shown previously in vitro (Kyle et al., 2012) and more recently
in vivo (Saha et al., 2019).
The use of SAP hydrogels in tissue engineering in general,
and regeneration of the oro-dento–alveolar complex in particular,
has shown promising results to date (Pugliese and Gelain, 2017).
The fact that P11-4 forms hydrogels proved to be beneficial
to its application as it allowed the scaffold to be injected
into the periodontal defects. Injectability is considered one of
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the favorable attributes of scaffolds used in tissue regeneration
applications (Chang et al., 2017).
Defects treated with P11-4 demonstrated evidence of highly
organized regenerated gingiva and PDL fibers, especially at the
4 weeks’ post-surgery time point as opposed to untreated controls
which demonstrated filling of the defects with CT of limited
organization, leading to statistically significant reduction of
epithelial down-growth and increase in the mean relative length
of functional PDL after 4 weeks. Furthermore, the CT in P11-4-
treated defects appeared healthier, with a high condensation of
newly formed blood capillaries which promote wound healing
(Guo and DiPietro, 2010). Our results are consistent with
the findings of others using different SAPs, who concluded
that SAP nanofiber scaffolds accelerate wound healing and
re-epithelialization (Schneider et al., 2008; Meng et al., 2009;
Yoshida et al., 2019).
The noticeable impact of P11-4 on gingival and PDL
regeneration may be related to the findings of Kyle et al.
(2012) who demonstrated that primary human dermal fibroblasts
infiltrated P11-4 hydrogels and aligned at the periphery. Cell
numbers within the hydrogel increased over a period of 4 weeks
similar to collagen scaffolds and the cells appeared to use the P11-
4 fibrillar network as a scaffold, similar to ECM proteins, during
the first 14 days of incubation. After this, the P11-4 hydrogels
started to degrade and were replaced by newly formed ECM
secreted from the cells (Kyle et al., 2012). The orientation of
collagen fibers and gingival fibroblasts seen in association with
P11-4 treatment in our study is of importance to functionality
of the PDL and may reflect the responsiveness of SAP gels to
prevalent shear forces (Scanlon et al., 2009).
Despite the fact that P11-4 hydrogels failed to produce a
significant increase in AB height at 4 weeks, the architectural
quality of regenerated bone was improved, with well-defined
trabecular structure seen in the P11-4 defects. The lack of
significant AB height is possibly due to the deficiencies in the
material properties (i.e., gel stiffness) of the peptide coupled with
the possible degradation of the peptide in situ, it is entirely
possible that the peptides persistence in the wound site is
relatively short. The study presented here did not look at the
degradation profile of the peptide, any future larger studies
would examine the peptides presence as a function of time.
None the less our data indicates a positive effect with the use
of P11-4.
Regenerated CT adjacent to root and newly formed bone
showed significantly higher levels of OC, OPG, and OPG/RANKL
in the P11-4-treated defects, suggesting a more favorable
environment for osteogenesis; they also help explain the
enhanced histological features of the newly formed bone. P11-4 is
able to induce hydroxyapatite nucleation de novo (Kirkham et al.,
2007), underpinning its use in enamel repair and regeneration
(Schlee et al., 2013). Taken together with our own data, this SAP
may be a promising osteoconductive scaffold.
It is well known that PR following PD is challenging due
to the complexity of periodontal architecture (Lin et al., 2015).
We have shown that the quality and organization of regenerated
periodontal tissues appeared to be more favorable following
the application of P11-4 compared with untreated defects. The
orientation and organization of type I collagen appeared to be
well developed 4 weeks after treatment with P11-4. In addition,
AB showed enhanced trabecular configuration. This may be due
to the unique features of the SAP including its resemblance
to natural ECM which acts as a temporary template for the
formative cells until replacement with newly formed ECM
(Lin et al., 2015).
The normal histological structure of periodontium in the
molar region in Sprague Dawley rats, is noted to show great
resemblance to that of humans. The similarities include the
structure and organization of junctional epithelium, periodontal
collagen fibers and alveolar bone (Listgarten, 1975; Page and
Schroeder, 1982; Ekuni et al., 2014). All study groups showed
a degree of epithelial downgrowth when considering normal
structure. This is known to be a common finding in periodontium
being regenerated after loss (Usuda et al., 2004). However, our
results showed more favorable results with P11-4 as shown by
the significant decrease in epithelial downgrowth after 4 weeks in
the P11-4 treated group. The orientation of regenerated oblique
PDL fibers and the architecture of regenerated AB trabeculae in
the P11-4 group was comparable to normal rat oblique PDL and
AB, particularly after 4 weeks. On the other hand, the orientation
of regenerated PDL fibers and the structure of regenerated AB
was far less organized in the untreated group. The PDL length
and AB height did not appear to return to their normal levels
in any of the study groups. This may be due to the fact that the
time points in our study were 2 and 4 weeks. Observation at a
later time point may have given a larger window for structures to
reach levels comparable to normal. However, when comparing
the functional PDL length between both study groups, it was
found to be significantly greater in the P11-4 treated group
after 4 weeks. Also, on comparing AB height between the study
groups at 4 weeks, it was found to be of higher values in the
P11-4 group.
Our findings indicate that P11-4 treatment enhanced PR after
2 weeks and that this was further promoted 4 weeks post-
surgery. Histomorphometry showed a significant increase in
functional ligament length and a significant decrease in epithelial
down-growth only after 4 weeks. In addition, although the
relative AB height was less with P11-4 at 2 weeks, bone growth
not only caught up with the untreated group but exceeded it
after 4 weeks. The finding that OPG/RANKL ratios increased
with time in P11-4 treated defects was particularly encouraging.
This is consistent with previous investigations that found a
significant effect for P11-4 after 4 weeks (Kirkham et al., 2007;
Kyle et al., 2012).
The level of OC was greater in the P11-4 treated groups after
4 weeks. However, this increase was statistically non-significant.
Evaluating the defects at a later time point, in addition to those
included in the study, might have given more time for the
regeneration to proceed and give us a deeper insight to the effects
of P11-4 on periodontal tissue regeneration.
Although a degradation profile of P11-4 was not measured in
this study, the findings of a previous study could offer an insight
to this. P11-4 was proven to start resorbing after 14 days in the
presence of dermal fibroblasts as opposed to the control group
of P11-4 matrix without cells (Kyle et al., 2012). The authors
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 9 September 2020 | Volume 8 | Article 559494
fbioe-08-559494 September 26, 2020 Time: 10:43 # 10
El-Sayed et al. Periodontal Regeneration Using SAP P11-4
concluded that the cells used the P11-4 matrix as a temporary
scaffold over the 14 days to deposit ECM matrix. These findings
show that the P11-4 when used in vivo may degrade at a rate
similar to the rate of formation of new tissues.
Also another more recent study (Saha et al., 2019) investigated
the effects of P11-4 in rat cranial defects. They showed
that P11-4 degraded at a slower rate compared to P11-
4 combined with HDPSCs. The authors also noted that
defects filled with P11-4 alone demonstrated enhanced bone
volume. It was concluded that this was more favorable for
osteogenesis and bone remodeling as the ability of P11-4
nucleate hydroxyapatite crystals would be lost if p11-4 degraded
at a quicker rate.
The acute defect model used here provides initial proof of
concept and demonstrates the regenerative ability of P11-4. This
was a surgically induced defect and not caused by chronic
inflammation as is characteristic of human periodontal defects.
Notwithstanding this, our study showed that P11-4 treatment
clearly improved the outcome in terms of periodontal tissue
regeneration compared with non-treated defects. In conclusion,
P11-4 SAPs are promising candidates for the treatment of
periodontal defects, used alone or as a scaffold combined
with other components to enhance PR. Further investigations
are required to determine its potential use in periodontal
regenerative therapy.
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